Medicinal Chemistry Director

Location Poland
Offer description

We are proud to collaborate with an innovative biotechnology company, which is looking for:

Medicinal Chemistry Director

Location: Poland



Together with an innovative European biotech company we are looking for an established and skilled scientific leader, with substantial experience in biotech industry who will play a strategic role in guiding the medicinal chemistry department, which operates in ligand-based and structure-based design of small molecules.


This position will be part of the core leadership within discovery chemistry and oversees internal and external medicinal chemistry resources to advance small molecule drug discovery projects to critical decision-making milestones, from target validation, hit identification to clinical candidate selection.


This is a wonderful opportunity for someone highly motivated and proactive, to join a Company developing world-changing therapies in oncology.

  • Contribute to discovery chemistry global strategy, vision and operation.
  • Leading chemistry team through good scientific judgement and smooth project execution in collaboration with cross functional research team.
  • Active engagement in preclinical drug development.
  • Stays informed on trends and emerging developments regarding research and development in the fields of oncology and immuno-oncology.
  • Communicates science and strategy effectively in a variety of internal and external settings.
Required skills
  • PhD in a relevant field – medicinal/organic/synthetic chemistry.
  • Demonstrated track record of being a leader and a team player, with hands-on experience in leading science teams towards delivery of novel therapeutics.
  • 10+ years of working experience in drug discovery/development in industry (pharma or biotech).
  • Strong experience in lead generation strategies (structure-based, fragment-based drug design) and exposure to a broad range of therapeutic targets and chemical modalities.
  • Excellent expertise in working with small molecule drug candidates, especially in oncology.
  • In-depth expertise in preclinical drug development.
Last modified Friday, October 16, 2020